Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2012 (2012), Article ID 605302, 11 pages
Review Article

PPARs and HCV-Related Hepatocarcinoma: A Mitochondrial Point of View

1Laboratory of Pre-Clinical and Translational Research, IRCCS, Centro di Riferimento Oncologico della Basilicata, 85028 Rionero in Vulture (Pz), Italy
2Department of Clinical and Experimental Medicine, University of Foggia, 71100 Foggia, Italy

Received 8 June 2012; Accepted 16 July 2012

Academic Editor: Valerio Pazienza

Copyright © 2012 Francesca Agriesti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Kung-Chia Young, Chyi-Huey Bai, Hui-Chen Su, Pei-Ju Tsai, Chien-Yu Pu, Chao-Sheng Liao, Yu-Min Lin, Hsin-Wen Lai, Lee-Won Chong, Yau-Sheng Tsai, and Chiung-Wen Tsao, “Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways,” Antiviral Research, 2014. View at Publisher · View at Google Scholar
  • G. Grammatikos, H. Farnik, D. Bon, A. Böhlig, T. Bader, T. Berg, S. Zeuzem, and E. Herrmann, “The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis,” Journal of Viral Hepatitis, 2014. View at Publisher · View at Google Scholar
  • Ming-Ling Chang, “Metabolic alterations and hepatitis C: From bench to bedside,” World Journal Of Gastroenterology, vol. 22, no. 4, pp. 1461–1476, 2016. View at Publisher · View at Google Scholar